Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| REVLON INC /DE/REVRQ · Entity 115224 | Director · 10% owner | November 08, 2022 | November 10, 2022 |
| SIGA TECHNOLOGIES INCSIGA · Entity 6205 | Director · 10% owner | November 16, 2016 | November 18, 2016 |
| vTv Therapeutics Inc.VTVT · Entity 6614 | 10% owner | December 20, 2021 | December 21, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
REVLON INC /DE/
Report date November 08, 2022 · Filed November 10, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectOwned through wholly owned corporations | 41,676,969 |
Reported balance
After 2022-11-08 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2022-11-08 · Sale · Disposed 4,546,352 · Balance 41,676,969 F1: The shares were sold to RCH Holdings Six Inc. by Perelman Trust Company, LLC, over which MacAndrews & Forbes Incorporated ("M&F") exercises voting control, in exchange for cash consideration of $45,463.52. Mr. Perelman is the sole stockholder of M&F. The transaction was effectuated to implement certain philanthropic endeavors for Mr. Perelman. F2: Of the 41,676,969 shares of Class A Common Stock reported herein, (i) 36,470,036 shares of Class A Common Stock are owned by M&F or its wholly owned subsidiaries; and (ii) 5,206,933 shares of Class A Common Stock are owned by RCH Holdings Five Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold to RCH Holdings Six Inc. by Perelman Trust Company, LLC, over which MacAndrews & Forbes Incorporated ("M&F") exercises voting control, in exchange for cash consideration of $45,463.52. Mr. Perelman is the sole stockholder of M&F. The transaction was effectuated to implement certain philanthropic endeavors for Mr. Perelman.
F2: Of the 41,676,969 shares of Class A Common Stock reported herein, (i) 36,470,036 shares of Class A Common Stock are owned by M&F or its wholly owned subsidiaries; and (ii) 5,206,933 shares of Class A Common Stock are owned by RCH Holdings Five Inc.
SIGA TECHNOLOGIES INC
Report date November 16, 2016 · Filed November 18, 2016
Jointly reported with MacAndrews & Forbes Inc., MacAndrews & Forbes LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, Par Value $.0001 Per ShareSEC Table I · non-derivative | IndirectOwned through wholly-owned company | 24,156,358 |
Last balance in matching sequence
After 2016-11-16 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2016-11-16 · Exercise / conversion · Acquired 10,060,643 · Balance 23,591,348 F1: On October 21, 2016, SIGA Technologies, Inc. (the "Company") issued a press release announcing the commencement of a pro rata offering (the "Rights Offering") of rights to holders of the Company's common stock, par value $.0001 per share ("Common Stock"), as of the record date of October 12, 2016, to subscribe for up to an aggregate of $35,284,792 in Common Stock. Each subscription right entitled its holder to invest $0.65 towards the purchase of shares of the Company's Common Stock at a subscription price equal to the lower of $1.50 or 85% of the volume weighted average price of the Common Stock during market hours on the expiration date of the Rights Offering, conditioned on the Company obtaining sufficient proceeds from the Rights Offering and a proposed loan transaction to permit the Company to satisfy certain obligations, together with other conditions outside the control of the reporting persons (all, the "Conditions"), (continued in footnote 2) F2: (continued from footnote 1) as more fully described in the Company's prospectus relating to the Rights Offering filed with the Securities Exchange Commission on October 21, 2016. Accordingly, the reporting persons were entitled to use basic subscription rights to subscribe for up to approximately $8,781,319 in Common Stock. Furthermore, the reporting persons were also entitled to subscribe for additional shares of common stock through an oversubscription process. Upon the expiration of the Rights Offering on November 8, 2016, the subscription price was fixed at $1.50 per share of Common Stock. The Conditions were satisfied on November 16, 2016. The reporting persons exercised their basic subscription in full and oversubscription rights. Pursuant to the reporting persons' basic subscription rights, they acquired 5,854,212 shares of Common Stock. The reporting persons acquired 4,206,431 shares pursuant to their exercise of their oversubscription rights. F3: Ronald O. Perelman beneficially owns 100% of the common stock of MacAndrews & Forbes Incorporated, which in turn is the sole member of MacAndrews & Forbes LLC. Certain direct or indirect wholly-owned subsidiaries of those reporting persons hold the securities described above. Row 2 · 2016-11-16 · Grant · Acquired 565,010 · Balance 24,156,358 F4: On October 13, 2016, the Company entered into an investment agreement relating to the Rights Offering (the "Backstop Agreement"), with a direct or indirect subsidiary of the reporting persons ("Buyer") and other persons (together, the "Backstop Parties"). Under the terms of the Backstop Agreement, Buyer agreed to purchase, pursuant to a separate private placement, 79.744% of any unsubscribed shares of Common Stock offered in the Rights Offering, at the same price per share of Common Stock to be paid in the Rights Offering. The Backstop Parties, taken together, were entitled to a fee of $1.76 million for providing the backstop commitment, payable, at the option of the Company, in cash or stock or, subject to the mutual agreement of the parties, other equity securities, with Buyer entitled to 79.744% of that fee. (continued in footnote 5) F5: (continued from footnote 4) The Company delivered a total of 565,010 shares of Common Stock to Buyer in satisfaction of the fee due under the Backstop Agreement, but no other shares were acquired pursuant to the Backstop Agreement. F3: Ronald O. Perelman beneficially owns 100% of the common stock of MacAndrews & Forbes Incorporated, which in turn is the sole member of MacAndrews & Forbes LLC. Certain direct or indirect wholly-owned subsidiaries of those reporting persons hold the securities described above. |
| Subscription Rights (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.50 · Expires 2016-11-08 | IndirectOwned through wholly-owned company | 0 |
Reported balance
After 2016-11-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-11-16 · Exercise / conversion · Disposed 0 · Balance 0 F1: On October 21, 2016, SIGA Technologies, Inc. (the "Company") issued a press release announcing the commencement of a pro rata offering (the "Rights Offering") of rights to holders of the Company's common stock, par value $.0001 per share ("Common Stock"), as of the record date of October 12, 2016, to subscribe for up to an aggregate of $35,284,792 in Common Stock. Each subscription right entitled its holder to invest $0.65 towards the purchase of shares of the Company's Common Stock at a subscription price equal to the lower of $1.50 or 85% of the volume weighted average price of the Common Stock during market hours on the expiration date of the Rights Offering, conditioned on the Company obtaining sufficient proceeds from the Rights Offering and a proposed loan transaction to permit the Company to satisfy certain obligations, together with other conditions outside the control of the reporting persons (all, the "Conditions"), (continued in footnote 2) F2: (continued from footnote 1) as more fully described in the Company's prospectus relating to the Rights Offering filed with the Securities Exchange Commission on October 21, 2016. Accordingly, the reporting persons were entitled to use basic subscription rights to subscribe for up to approximately $8,781,319 in Common Stock. Furthermore, the reporting persons were also entitled to subscribe for additional shares of common stock through an oversubscription process. Upon the expiration of the Rights Offering on November 8, 2016, the subscription price was fixed at $1.50 per share of Common Stock. The Conditions were satisfied on November 16, 2016. The reporting persons exercised their basic subscription in full and oversubscription rights. Pursuant to the reporting persons' basic subscription rights, they acquired 5,854,212 shares of Common Stock. The reporting persons acquired 4,206,431 shares pursuant to their exercise of their oversubscription rights. F3: Ronald O. Perelman beneficially owns 100% of the common stock of MacAndrews & Forbes Incorporated, which in turn is the sole member of MacAndrews & Forbes LLC. Certain direct or indirect wholly-owned subsidiaries of those reporting persons hold the securities described above. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 21, 2016, SIGA Technologies, Inc. (the "Company") issued a press release announcing the commencement of a pro rata offering (the "Rights Offering") of rights to holders of the Company's common stock, par value $.0001 per share ("Common Stock"), as of the record date of October 12, 2016, to subscribe for up to an aggregate of $35,284,792 in Common Stock. Each subscription right entitled its holder to invest $0.65 towards the purchase of shares of the Company's Common Stock at a subscription price equal to the lower of $1.50 or 85% of the volume weighted average price of the Common Stock during market hours on the expiration date of the Rights Offering, conditioned on the Company obtaining sufficient proceeds from the Rights Offering and a proposed loan transaction to permit the Company to satisfy certain obligations, together with other conditions outside the control of the reporting persons (all, the "Conditions"), (continued in footnote 2)
F2: (continued from footnote 1) as more fully described in the Company's prospectus relating to the Rights Offering filed with the Securities Exchange Commission on October 21, 2016. Accordingly, the reporting persons were entitled to use basic subscription rights to subscribe for up to approximately $8,781,319 in Common Stock. Furthermore, the reporting persons were also entitled to subscribe for additional shares of common stock through an oversubscription process. Upon the expiration of the Rights Offering on November 8, 2016, the subscription price was fixed at $1.50 per share of Common Stock. The Conditions were satisfied on November 16, 2016. The reporting persons exercised their basic subscription in full and oversubscription rights. Pursuant to the reporting persons' basic subscription rights, they acquired 5,854,212 shares of Common Stock. The reporting persons acquired 4,206,431 shares pursuant to their exercise of their oversubscription rights.
F3: Ronald O. Perelman beneficially owns 100% of the common stock of MacAndrews & Forbes Incorporated, which in turn is the sole member of MacAndrews & Forbes LLC. Certain direct or indirect wholly-owned subsidiaries of those reporting persons hold the securities described above.
F4: On October 13, 2016, the Company entered into an investment agreement relating to the Rights Offering (the "Backstop Agreement"), with a direct or indirect subsidiary of the reporting persons ("Buyer") and other persons (together, the "Backstop Parties"). Under the terms of the Backstop Agreement, Buyer agreed to purchase, pursuant to a separate private placement, 79.744% of any unsubscribed shares of Common Stock offered in the Rights Offering, at the same price per share of Common Stock to be paid in the Rights Offering. The Backstop Parties, taken together, were entitled to a fee of $1.76 million for providing the backstop commitment, payable, at the option of the Company, in cash or stock or, subject to the mutual agreement of the parties, other equity securities, with Buyer entitled to 79.744% of that fee. (continued in footnote 5)
F5: (continued from footnote 4) The Company delivered a total of 565,010 shares of Common Stock to Buyer in satisfaction of the fee due under the Backstop Agreement, but no other shares were acquired pursuant to the Backstop Agreement.
vTv Therapeutics Inc.
Report date December 20, 2021 · Filed December 21, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 36,519,212 |
Reported balance
After 2021-12-20 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2021-12-20 · Sale · Disposed 87,000 · Balance 36,519,212 F1: The ROP Revocable Trust dated 1/9/2018 (the "ROP Revocable Trust"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). The ROP Revocable Trust is also the sole stockholder of Thirty Six East Corporation ("Thirty Six East"). M&F Group, MFV and Thirty Six East hold the securities described above. (cont'd on FN 2) F2: (cont'd from FN 1) Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group, MFV and Thirty Six East may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of the role of Rich Nelson, director of the Issuer, as Executive Vice President Corporate and Business Development of Vericast and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: The ROP Revocable Trust dated 1/9/2018 (the "ROP Revocable Trust"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). The ROP Revocable Trust is also the sole stockholder of Thirty Six East Corporation ("Thirty Six East"). M&F Group, MFV and Thirty Six East hold the securities described above. (cont'd on FN 2)
F2: (cont'd from FN 1) Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group, MFV and Thirty Six East may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of the role of Rich Nelson, director of the Issuer, as Executive Vice President Corporate and Business Development of Vericast and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Light & Wonder, Inc.
Report date October 12, 2020 · Filed October 13, 2020
Section 16 reporting ended · disclosed 2020-10-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 8,871,313 |
Reported balance
After 2020-10-12 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2020-10-12 · Sale · Disposed 1,964,285 · Balance 8,871,313 F1: Mr. Perelman is the sole beneficiary and trustee of The ROP Revocable Trust dated 1/9/2018 (the "Trust"), which directly holds 122,728 shares of Common Stock. The Trust is also the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC and MacAndrews & Forbes Group, LLC, which hold the remaining securities described above. Mr. Perelman does not own any shares of Common Stock directly. On October 12, 2020, SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC and SGMS Acquisition Three LLC sold an aggregate of 1,964,285 shares of Common Stock pursuant to the previously disclosed Stock Purchase Agreement by and among SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC, MacAndrews & Forbes Group, LLC and Pivot Buyer LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Perelman is the sole beneficiary and trustee of The ROP Revocable Trust dated 1/9/2018 (the "Trust"), which directly holds 122,728 shares of Common Stock. The Trust is also the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC and MacAndrews & Forbes Group, LLC, which hold the remaining securities described above. Mr. Perelman does not own any shares of Common Stock directly. On October 12, 2020, SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC and SGMS Acquisition Three LLC sold an aggregate of 1,964,285 shares of Common Stock pursuant to the previously disclosed Stock Purchase Agreement by and among SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC, MacAndrews & Forbes Group, LLC and Pivot Buyer LLC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 29, 2018 Filed Nov 30, 2018 16:30 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | PurchaseClass A common stock | 1,879,700 | $1.33 | $2,500,001.00 |
DisclosureSEC source: 0001140361-18-044269 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 12,417,568 F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| November 06, 2018 Filed Nov 7, 2018 06:55 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCall Option (right to buy) · Derivative | 1 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0001140361-18-042594 · form4.xml · derivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 1,879,699 shares Expires 2019-07-30 F2 · kind: On July 30, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.33, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On November 6, 2018, the Issuer exercised its right to have M&F Group purchase 1,879,699 shares of Common Stock for a total purchase price of $2,500,000 in cash. F2 · balance_after: On July 30, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.33, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On November 6, 2018, the Issuer exercised its right to have M&F Group purchase 1,879,699 shares of Common Stock for a total purchase price of $2,500,000 in cash. F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| November 06, 2018 Filed Nov 7, 2018 06:55 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | PurchaseClass A common stock | 1,879,699 | $1.33 | $2,499,999.67 |
DisclosureSEC source: 0001140361-18-042594 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,537,868 F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| September 27, 2018 Filed Oct 1, 2018 18:37 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCall Option (right to buy) · Derivative | 1 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0001140361-18-039790 · form4.xml · derivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 1,879,699 shares Expires 2019-07-30 F2 · kind: On July 30, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.33, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On September 27, 2018, the Issuer exercised its right to have M&F Group purchase 1,879,699 shares of Common Stock for a total purchase price of $2,500,000 in cash. F2 · balance_after: On July 30, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.33, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On September 27, 2018, the Issuer exercised its right to have M&F Group purchase 1,879,699 shares of Common Stock for a total purchase price of $2,500,000 in cash. F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| September 27, 2018 Filed Oct 1, 2018 18:37 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | PurchaseClass A common stock | 1,879,699 | $1.33 | $2,499,999.67 |
DisclosureSEC source: 0001140361-18-039790 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 8,658,169 F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| September 25, 2018 Filed Sep 25, 2018 17:57 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 35,000 | $21.50 | $752,374.00 |
DisclosureSEC source: 0001209191-18-052191 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 2 Disclosed balance after: 45,002,130 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $21.4964 reported in Column 4 is the weighted average purchase price for the 35,000 shares acquired by the Reporting Person within a range of $21.15 to $21.95 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F2 · balance_after: Of the 45,002,130 shares of Class A Common Stock reported herein, (i) 40,455,778 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F"), of which Ronald O. Perelman is the sole stockholder, or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control. Read SEC document |
| September 21, 2018 Filed Sep 24, 2018 08:34 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 50,220 | $21.29 | $1,069,213.93 |
DisclosureSEC source: 0001209191-18-052008 · doc4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 3 Disclosed balance after: 44,967,130 F2 · price: The reported transactions were executed in multiple trades. The purchase price of $21.2906 reported in Column 4 is the weighted average purchase price for the 50,220 shares acquired by the Reporting Person within a range of $21.00 to $21.53 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F3 · balance_after: Of the 44,967,130 shares of Class A Common Stock reported herein, (i) 40,420,778 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F"), of which Ronald O. Perelman is the sole stockholder, or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control. Read SEC document |
| September 21, 2018 Filed Sep 24, 2018 08:34 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 49,780 | $20.60 | $1,025,572.54 |
DisclosureSEC source: 0001209191-18-052008 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 3 Disclosed balance after: 44,916,910 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $20.6021 reported in Column 4 is the weighted average purchase price for the 49,780 shares acquired by the Reporting Person within a range of $20.20 to $20.95 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| September 13, 2018 Filed Sep 13, 2018 19:41 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 20,000 | $20.88 | $417,662.00 |
DisclosureSEC source: 0001209191-18-050965 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 2 Disclosed balance after: 44,867,130 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $20.8831 reported in Column 4 is the weighted average purchase price for the 20,000 shares acquired by the Reporting Person within a range of $20.50 to $21.20 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F2 · balance_after: Of the 44,867,130 shares of Class A Common Stock reported herein, (i) 40,320,778 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F"), of which Ronald O. Perelman is the sole stockholder, or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control. Read SEC document |
| September 06, 2018 Filed Sep 10, 2018 17:46 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCall Option (right to buy) · Derivative | 1 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0001140361-18-038190 · form4.xml · derivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 1,879,699 shares Expires 2019-07-30 F2 · kind: On July 30, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.33, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On September 6, 2018, the Issuer exercised its right to have M&F Group purchase 1,879,699 shares of Common Stock for a total purchase price of $2,500,000 in cash. F2 · balance_after: On July 30, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.33, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On September 6, 2018, the Issuer exercised its right to have M&F Group purchase 1,879,699 shares of Common Stock for a total purchase price of $2,500,000 in cash. F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| September 06, 2018 Filed Sep 10, 2018 17:46 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | PurchaseClass A common stock | 1,879,699 | $1.33 | $2,499,999.67 |
DisclosureSEC source: 0001140361-18-038190 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,778,470 F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| August 20, 2018 Filed Aug 20, 2018 17:29 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 10,000 | $17.45 | $174,488.00 |
DisclosureSEC source: 0001209191-18-047637 · doc4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 3 Disclosed balance after: 44,847,130 F2 · price: The reported transactions were executed in multiple trades. The purchase price of $17.4488 reported in Column 4 is the weighted average purchase price for the 10,000 shares acquired by the Reporting Person within a range of $17.40 to $17.55 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F3 · balance_after: Of the 44,847,130 shares of Class A Common Stock reported herein, (i) 40,300,778 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F"), of which Ronald O. Perelman is the sole stockholder, or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control. Read SEC document |
| August 17, 2018 Filed Aug 20, 2018 17:29 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 10,000 | $17.49 | $174,903.00 |
DisclosureSEC source: 0001209191-18-047637 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 3 Disclosed balance after: 44,837,130 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $17.4903 reported in Column 4 is the weighted average purchase price for the 10,000 shares acquired by the Reporting Person within a range of $17.35 to $17.60 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| August 16, 2018 Filed Aug 16, 2018 17:44 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 20,000 | $17.52 | $350,398.00 |
DisclosureSEC source: 0001209191-18-047157 · doc4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 3 Disclosed balance after: 44,827,130 F2 · price: The reported transactions were executed in multiple trades. The purchase price of $17.5199 reported in Column 4 is the weighted average purchase price for the 20,000 shares acquired by the Reporting Person within a range of $17.40 to $17.60 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F3 · balance_after: Of the 44,827,130 shares of Class A Common Stock reported herein, (i) 40,280,778 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F"), of which Ronald O. Perelman is the sole stockholder, or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control. Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 17:44 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 20,000 | $17.80 | $356,022.00 |
DisclosureSEC source: 0001209191-18-047157 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 3 Disclosed balance after: 44,807,130 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $17.8011 reported in Column 4 is the weighted average purchase price for the 20,000 shares acquired by the Reporting Person within a range of $17.25 to $18.00 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| August 14, 2018 Filed Aug 14, 2018 20:49 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 25,000 | $17.49 | $437,210.00 |
DisclosureSEC source: 0001209191-18-046704 · doc4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 3 Disclosed balance after: 44,787,130 F2 · price: The reported transactions were executed in multiple trades. The purchase price of $17.4884 reported in Column 4 is the weighted average purchase price for the 25,000 shares acquired by the Reporting Person within a range of $17.25 to $17.75 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F3 · balance_after: Of the 44,787,130 shares of Class A Common Stock reported herein, (i) 40,240,778 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F"), of which Ronald O. Perelman is the sole stockholder, or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control. Read SEC document |
| August 13, 2018 Filed Aug 14, 2018 01:53 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | PurchaseCommon Stock | 72,924 | $31.95 | $2,329,921.80 |
DisclosureSEC source: 0000950157-18-000905 · form4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 34,750,736 F2 · price: The transaction was executed in multiple trades at prices ranging from $31.83 to $32.20. The price reported above reflects the weighted average purchase price. Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer. F3 · ownership.nature: Mr. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder of each of SGMS Acquisition Corporation, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC, MFV Holdings One LLC and RLX Holdings Two LLC, which hold the securities described above. Read SEC document |
| August 13, 2018 Filed Aug 14, 2018 01:53 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | PurchaseCommon Stock | 102,076 | $31.57 | $3,222,539.32 |
DisclosureSEC source: 0000950157-18-000905 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 34,677,812 F1 · price: The transaction was executed in multiple trades at prices ranging from $31.20 to $31.80. The price reported above reflects the weighted average purchase price. Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer. F3 · ownership.nature: Mr. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder of each of SGMS Acquisition Corporation, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC, MFV Holdings One LLC and RLX Holdings Two LLC, which hold the securities described above. Read SEC document |
| August 13, 2018 Filed Aug 14, 2018 20:49 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 50,000 | $17.20 | $860,035.00 |
DisclosureSEC source: 0001209191-18-046704 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 3 Disclosed balance after: 44,762,130 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $17.2007 reported in Column 4 is the weighted average purchase price for the 50,000 shares acquired by the Reporting Person within a range of $16.80 to $17.55 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 08:58 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 51,097 | $17.05 | $871,004.57 |
DisclosureSEC source: 0001209191-18-046339 · doc4.xml · nonDerivative · entry 4 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 5 Disclosed balance after: 44,712,130 F4 · price: The reported transactions were executed in multiple trades. The purchase price of $17.0461 reported in Column 4 is the weighted average purchase price for the 51,097 shares acquired by the Reporting Person within a range of $16.75 to $17.50 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F5 · ownership.nature: Of the 44,712,130 shares of Class A Common Stock reported herein, (i) 40,165,778 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F"), of which Ronald O. Perelman is the sole stockholder, or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control. Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 08:58 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 23,903 | $16.33 | $390,292.96 |
DisclosureSEC source: 0001209191-18-046339 · doc4.xml · nonDerivative · entry 3 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 5 Disclosed balance after: 44,661,033 F3 · price: The reported transactions were executed in multiple trades. The purchase price of $16.3282 reported in Column 4 is the weighted average purchase price for the 23,903 shares acquired by the Reporting Person within a range of $15.75 to $16.70 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| August 10, 2018 Filed Aug 14, 2018 16:50 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCall Option (right to buy) · Derivative | 1 | $0.00 Strike: $4.38 | $0.00 |
DisclosureSEC source: 0001140361-18-036378 · form4.xml · derivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class A common stock · 570,777 shares Expires 2018-12-05 F2 · kind: On December 5, 2017, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $4.38, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On August 10, 2018, the Issuer exercised its right to have M&F Group purchase the final 570,777 shares of Common Stock for a total purchase price of $2,500,000 in cash. F2 · balance_after: On December 5, 2017, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $4.38, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On August 10, 2018, the Issuer exercised its right to have M&F Group purchase the final 570,777 shares of Common Stock for a total purchase price of $2,500,000 in cash. F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| August 10, 2018 Filed Aug 14, 2018 16:50 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | PurchaseClass A common stock | 570,777 | $4.38 | $2,500,003.26 |
DisclosureSEC source: 0001140361-18-036378 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,898,771 F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 08:58 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 53,825 | $15.88 | $854,821.74 |
DisclosureSEC source: 0001209191-18-046339 · doc4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 5 Disclosed balance after: 44,637,130 F2 · price: The reported transactions were executed in multiple trades. The purchase price of $15.8815 reported in Column 4 is the weighted average purchase price for the 53,825 shares acquired by the Reporting Person within a range of $15.30 to $16.15 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 08:58 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 10,118 | $15.18 | $153,542.67 |
DisclosureSEC source: 0001209191-18-046339 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 5 Disclosed balance after: 44,583,305 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $15.1752 reported in Column 4 is the weighted average purchase price for the 10,118 shares acquired by the Reporting Person within a range of $15.00 to $15.25 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 16:58 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCommon Stock Purchase Warrant · Derivative | 1 | Not disclosed Strike: $1.53 | Not disclosed |
DisclosureSEC source: 0001140361-18-034821 · form4.xml · derivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 518,654 shares Expires 2025-07-30 F2 · kind: In consideration for the commitment of M&F Group under the Letter Agreement, the Issuer issued M&F Group a warrant (the "Warrant") to purchase 518,654 shares of Common Stock, exercisable at a price of $1.53, which is 115% of the option price under the Letter Agreement. The Warrant is exercisable until July 30, 2025. F2 · price: In consideration for the commitment of M&F Group under the Letter Agreement, the Issuer issued M&F Group a warrant (the "Warrant") to purchase 518,654 shares of Common Stock, exercisable at a price of $1.53, which is 115% of the option price under the Letter Agreement. The Warrant is exercisable until July 30, 2025. F3 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of M&F Group. M&F Group holds the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of the Issuer by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 16:58 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCall Option (right to buy) · Derivative | 1 | Not disclosed Strike: $1.33 | Not disclosed |
DisclosureSEC source: 0001140361-18-034821 · form4.xml · derivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 7,518,797 shares Expires 2025-07-30 F1 · kind: On July 30, 2018, MacAndrews & Forbes Group LLC ("M&F Group") entered into a letter agreement (the "Letter Agreement"), with vTv Therapeutics Inc. (the "Issuer"), for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period after the date of the Letter Agreement (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock"), at a per share price of $1.33, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group (whether at its or the Issuer's option) pursuant to the Letter Agreement is limited to $10.0 million. F1 · price: On July 30, 2018, MacAndrews & Forbes Group LLC ("M&F Group") entered into a letter agreement (the "Letter Agreement"), with vTv Therapeutics Inc. (the "Issuer"), for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period after the date of the Letter Agreement (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock"), at a per share price of $1.33, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group (whether at its or the Issuer's option) pursuant to the Letter Agreement is limited to $10.0 million. F3 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of M&F Group. M&F Group holds the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of the Issuer by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| July 06, 2018 Filed Jul 10, 2018 16:55 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCall Option (right to buy) · Derivative | 1 | $0.00 Strike: $4.38 | $0.00 |
DisclosureSEC source: 0001140361-18-032044 · form4.xml · derivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 570,776 shares Expires 2018-12-05 F2 · kind: On December 5, 2017, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $4.38, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On July 6, 2018, the Issuer exercised its right to have M&F Group purchase 570,776 shares of Common Stock for a total purchase price of $2,500,000 in cash. F2 · balance_after: On December 5, 2017, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $4.38, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On July 6, 2018, the Issuer exercised its right to have M&F Group purchase 570,776 shares of Common Stock for a total purchase price of $2,500,000 in cash. F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| July 06, 2018 Filed Jul 10, 2018 16:55 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | PurchaseClass A common stock | 570,776 | $4.38 | $2,499,998.88 |
DisclosureSEC source: 0001140361-18-032044 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,327,994 F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| June 19, 2018 Filed Jun 21, 2018 20:46 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | Exercise / conversionRestricted Stock Units · Derivative | 1,554 | $0.00 | $0.00 |
DisclosureSEC source: 0000750004-18-000160 · wf-form4_152961397433610.xml · derivative · entry 3 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,665 Underlying: Common Stock · 1,554 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents vesting of one-fourth of restricted stock units granted on June 19, 2017. The balance of the award is scheduled to vest in three equal installments of 1,555 shares on each of June 19, 2019, 2020 and 2021. Each unit converts into a share of common stock on a one-for-one basis. F2 · derivative.exercise_date: Represents vesting of one-fourth of restricted stock units granted on June 19, 2017. The balance of the award is scheduled to vest in three equal installments of 1,555 shares on each of June 19, 2019, 2020 and 2021. Each unit converts into a share of common stock on a one-for-one basis. F2 · derivative.expiration_date: Represents vesting of one-fourth of restricted stock units granted on June 19, 2017. The balance of the award is scheduled to vest in three equal installments of 1,555 shares on each of June 19, 2019, 2020 and 2021. Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| June 19, 2018 Filed Jun 21, 2018 20:46 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | Exercise / conversionCommon Stock | 1,554 | $0.00 | $0.00 |
DisclosureSEC source: 0000750004-18-000160 · wf-form4_152961397433610.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2018 Filed Jun 20, 2018 16:30 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCall Option (right to buy) · Derivative | 1 | $0.00 Strike: $4.38 | $0.00 |
DisclosureSEC source: 0001140361-18-029309 · form4.xml · derivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 570,776 shares Expires 2018-12-05 F2 · kind: On December 5, 2017, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $4.38, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On June 18, 2018, the Issuer exercised its right to have M&F Group purchase 570,776 shares of Common Stock for a total purchase price of $2,500,000 in cash. F2 · balance_after: On December 5, 2017, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $4.38, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On June 18, 2018, the Issuer exercised its right to have M&F Group purchase 570,776 shares of Common Stock for a total purchase price of $2,500,000 in cash. F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| June 18, 2018 Filed Jun 20, 2018 16:30 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | PurchaseClass A common stock | 570,776 | $4.38 | $2,499,998.88 |
DisclosureSEC source: 0001140361-18-029309 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,757,218 F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| June 15, 2018 Filed Jun 15, 2018 20:48 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | Exercise / conversionRestricted Stock Units · Derivative | 4,338 | $0.00 | $0.00 |
DisclosureSEC source: 0000750004-18-000138 · wf-form4_152909569588132.xml · derivative · entry 4 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,677 Underlying: Common Stock · 4,338 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Represents vesting of one-fourth of restricted stock units granted on June 15, 2016. The balance of the award is scheduled to vest on June 15, 2019 (4,338 shares) and 2020 (4,339 shares). Each unit converts into a share of common stock on a one-for-one basis. F3 · derivative.exercise_date: Represents vesting of one-fourth of restricted stock units granted on June 15, 2016. The balance of the award is scheduled to vest on June 15, 2019 (4,338 shares) and 2020 (4,339 shares). Each unit converts into a share of common stock on a one-for-one basis. F3 · derivative.expiration_date: Represents vesting of one-fourth of restricted stock units granted on June 15, 2016. The balance of the award is scheduled to vest on June 15, 2019 (4,338 shares) and 2020 (4,339 shares). Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| June 15, 2018 Filed Jun 15, 2018 20:48 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | Exercise / conversionCommon Stock | 4,338 | $0.00 | $0.00 |
DisclosureSEC source: 0000750004-18-000138 · wf-form4_152909569588132.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 20:48 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | GrantRestricted Stock Units · Derivative | 2,787 | $0.00 | $0.00 |
DisclosureSEC source: 0000750004-18-000138 · wf-form4_152909569588132.xml · derivative · entry 3 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,787 Underlying: Common Stock · 2,787 shares Expires not disclosed F2 · derivative.exercise_price: The restricted stock units are scheduled to vest beginning on June 13, 2019 as to 696 shares and the balance in three equal installments as to 697 shares on each of 2020, 2021 and 2022. Each unit converts into a share of common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units are scheduled to vest beginning on June 13, 2019 as to 696 shares and the balance in three equal installments as to 697 shares on each of 2020, 2021 and 2022. Each unit converts into a share of common stock on a one-for-one basis. F2 · derivative.expiration_date: The restricted stock units are scheduled to vest beginning on June 13, 2019 as to 696 shares and the balance in three equal installments as to 697 shares on each of 2020, 2021 and 2022. Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| June 11, 2018 Filed Jun 12, 2018 23:22 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | Exercise / conversionRestricted Stock Units · Derivative | 3,495 | $0.00 | $0.00 |
DisclosureSEC source: 0000750004-18-000118 · wf-form4_152884574124402.xml · derivative · entry 5 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,495 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Represents vesting of one-fourth of restricted stock units granted on June 11, 2014. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F3 · derivative.exercise_date: Represents vesting of one-fourth of restricted stock units granted on June 11, 2014. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F3 · derivative.expiration_date: Represents vesting of one-fourth of restricted stock units granted on June 11, 2014. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| June 11, 2018 Filed Jun 12, 2018 23:22 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | Exercise / conversionCommon Stock | 3,495 | $0.00 | $0.00 |
DisclosureSEC source: 0000750004-18-000118 · wf-form4_152884574124402.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,140 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2018 Filed Jun 12, 2018 23:22 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | Exercise / conversionRestricted Stock Units · Derivative | 2,484 | $0.00 | $0.00 |
DisclosureSEC source: 0000750004-18-000118 · wf-form4_152884574124402.xml · derivative · entry 4 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,485 Underlying: Common Stock · 2,484 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents vesting of one-fourth of restricted stock units granted on June 10, 2015. The balance of the award (2,485 shares) is scheduled to vest on June 10, 2019. Each unit converts into a share of common stock on a one-for-one basis. F2 · derivative.exercise_date: Represents vesting of one-fourth of restricted stock units granted on June 10, 2015. The balance of the award (2,485 shares) is scheduled to vest on June 10, 2019. Each unit converts into a share of common stock on a one-for-one basis. F2 · derivative.expiration_date: Represents vesting of one-fourth of restricted stock units granted on June 10, 2015. The balance of the award (2,485 shares) is scheduled to vest on June 10, 2019. Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| June 10, 2018 Filed Jun 12, 2018 23:22 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | Exercise / conversionCommon Stock | 2,484 | $0.00 | $0.00 |
DisclosureSEC source: 0000750004-18-000118 · wf-form4_152884574124402.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2018 Filed May 29, 2018 16:59 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCall Option (right to buy) · Derivative | 1 | $0.00 Strike: $4.38 | $0.00 |
DisclosureSEC source: 0001140361-18-026027 · form4.xml · derivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 570,776 shares Expires 2018-12-05 F2 · kind: On December 5, 2017, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $4.38, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On May 24, 2018, the Issuer exercised its right to have M&F Group purchase 570,776 shares of Common Stock for a total purchase price of $2,500,000 in cash. F2 · balance_after: On December 5, 2017, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $4.38, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On May 24, 2018, the Issuer exercised its right to have M&F Group purchase 570,776 shares of Common Stock for a total purchase price of $2,500,000 in cash. F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| May 24, 2018 Filed May 29, 2018 16:59 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | PurchaseClass A common stock | 570,776 | $4.38 | $2,499,998.88 |
DisclosureSEC source: 0001140361-18-026027 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,186,442 F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| December 26, 2017 Filed Dec 27, 2017 16:43 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | PurchaseClass A common stock | 50,000 | $4.03 | $201,720.00 |
DisclosureSEC source: 0001140361-17-047493 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,615,666 F1 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.94 to $4.19, inclusive. The reporting person undertakes to provide to vTv Therapeutics Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote to this Form 4. F2 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of the Issuer by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| December 05, 2017 Filed Dec 7, 2017 17:17 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCommon Stock Purchase Warrant · Derivative | 1 | Not disclosed Strike: $5.04 | Not disclosed |
DisclosureSEC source: 0001140361-17-045354 · form4.xml · derivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 198,267 shares Expires 2024-12-05 F2 · kind: In consideration for the commitment of M&F Group under the Letter Agreement, the Issuer issued M&F Group a warrant (the "Warrant") to purchase 198,267 shares of Common Stock, exercisable at a price of $5.04, which is 115% of the option price under the Letter Agreement. The Warrant is exercisable until December 5, 2024. F2 · price: In consideration for the commitment of M&F Group under the Letter Agreement, the Issuer issued M&F Group a warrant (the "Warrant") to purchase 198,267 shares of Common Stock, exercisable at a price of $5.04, which is 115% of the option price under the Letter Agreement. The Warrant is exercisable until December 5, 2024. F3 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of M&F Group. M&F Group holds the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of the Issuer by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| December 05, 2017 Filed Dec 7, 2017 17:17 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCall Option (right to buy) · Derivative | 1 | Not disclosed Strike: $4.38 | Not disclosed |
DisclosureSEC source: 0001140361-17-045354 · form4.xml · derivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 2,283,105 shares Expires 2018-12-05 F1 · kind: On December 5, 2017, MacAndrews & Forbes Group LLC ("M&F Group") entered into a letter agreement (the "Letter Agreement"), with vTv Therapeutics Inc. (the "Issuer"), for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period after the date of the Letter Agreement (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $4.38, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group (whether at its or the Issuer's option) pursuant to the Letter Agreement is limited to $10.0 million. F1 · price: On December 5, 2017, MacAndrews & Forbes Group LLC ("M&F Group") entered into a letter agreement (the "Letter Agreement"), with vTv Therapeutics Inc. (the "Issuer"), for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period after the date of the Letter Agreement (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $4.38, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group (whether at its or the Issuer's option) pursuant to the Letter Agreement is limited to $10.0 million. F3 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of M&F Group. M&F Group holds the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of the Issuer by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| November 06, 2017 Filed Nov 6, 2017 18:00 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 47,355 | $22.43 | $1,062,059.00 |
DisclosureSEC source: 0001209191-17-059478 · doc4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 2 Disclosed balance after: 44,573,187 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $22.4276 reported in Column 4 is the weighted average purchase price for the 47,355 shares acquired by the Reporting Person within a range of $21.70 to $22.50 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F2 · balance_after: Of the 44,573,187 shares of Class A Common Stock reported herein, (i) 40,026,835 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F"), of which Ronald O. Perelman is the sole stockholder, or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control. 15,258 shares of Class A Common Stock that were beneficially owned by Mr. Raymond G. Perelman, which M&F may previously have been deemed to beneficially own due to an irrevocable voting proxy over such shares held by M&F, were donated to a charitable institution on November 2, 2017. Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 18:00 UTC | REVLON INC /DE/ REV · Entity 115224 | OtherClass A Common Stock | 15,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-059478 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 2 Disclosed balance after: 44,525,832 Read SEC document |
| September 26, 2017 Filed Sep 27, 2017 18:00 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 40,100 | $21.45 | $860,068.81 |
DisclosureSEC source: 0001209191-17-054167 · doc4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 3 Disclosed balance after: 44,541,090 F2 · price: The reported transactions were executed in multiple trades. The purchase price of $21.4481 reported in Column 4 is the weighted average purchase price for the 40,100 shares acquired by the Reporting Person within a range of $21.325 to $21.50 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F3 · balance_after: Of the 44,541,090 shares of Class A Common Stock reported herein, (i) 39,979,480 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F"), of which Ronald O. Perelman is the sole stockholder, or its wholly-owned subsidiaries; (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control; and (iii) 15,258 shares of Class A Common Stock are beneficially owned by Mr. Raymond G. Perelman (which shares M&F may also be deemed to beneficially own because M&F holds an irrevocable voting proxy with respect to such shares). Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 18:00 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 66,684 | $20.03 | $1,335,760.54 |
DisclosureSEC source: 0001209191-17-054167 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 3 Disclosed balance after: 44,500,990 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $20.0312 reported in Column 4 is the weighted average purchase price for the 66,684 shares acquired by the Reporting Person within a range of $19.40 to $20.25 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| September 21, 2017 Filed Sep 21, 2017 17:55 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 175,993 | $18.11 | $3,187,814.01 |
DisclosureSEC source: 0001209191-17-053641 · doc4.xml · nonDerivative · entry 4 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 5 Disclosed balance after: 44,434,306 F4 · price: The reported transactions were executed in multiple trades. The purchase price of $18.1133 reported in Column 4 is the weighted average purchase price for the 175,993 shares acquired by the Reporting Person within a range of $17.80 to $18.50 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F5 · balance_after: Of the 44,434,306 shares of Class A Common Stock reported herein, (i) 39,872,696 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F"), of which Ronald O. Perelman is the sole stockholder, or its wholly-owned subsidiaries; (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control; and (iii) 15,258 shares of Class A Common Stock are beneficially owned by Mr. Raymond G. Perelman (which shares M&F may also be deemed to beneficially own because M&F holds an irrevocable voting proxy with respect to such shares). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.